Analysis of In Vitro Cyto- and Genotoxicity of Barbatimão Extract on Human Keratinocytes and Fibroblasts
Open Access
- 8 October 2018
- journal article
- research article
- Published by Wiley in BioMed Research International
- Vol. 2018, 1-11
Abstract
Barbatimão (Stryphnodendron adstringens, Mart.) is a native Brazilian species used in traditional medicine and some commercial preparations owing to its strong wound-healing activity. However, controversy regarding its use due to safety concerns over the potential genotoxic effect of this plant remains. In order to clarify this issue, the effect of hydroalcoholic extract of barbatimão in vitro on cell viability, DNA damage, and induction of apoptosis in two commercial cell lines of keratinocytes (HaCaT) and fibroblasts (HFF-1) was evaluated. Barbatimão stem bark hydroalcoholic extract (70% ethanol) was obtained and lyophilized for subsequent use in all experiments. The main bioactive molecules quantified by HPLC were gallic acid, caffeic acid, quercetin, catechin, and epigallocatechin gallate (EGCG). Barbatimão (0.024 to 1.99 mg/mL) was found to decrease cellular mortality as compared to the control group. GEMO assay, a noncellular DNA protocol that uses H2O2-exposed calf thymus DNA, revealed not only a genotoxic effect of barbatimão, but also a potential genoprotective action against H2O2-triggered DNA fragmentation. These results indicated that barbatimão at concentrations of 0.49 and 0.99 mg/mL, which are near to the levels found in commercial preparations, exerted an in vitro genoprotective effect on cells by decreasing the levels of DNA oxidation quantified by 8-hydroxy-2′-deoxyguanosine (8-OHdG) and reactive oxygen species (ROS) levels. Gene and protein apoptotic markers, quantified by qRT-PCR (BAX/Bcl-2 genes) and immunoassays (Caspases 3 and 8), respectively, also indicated a decrease in apoptotic events in comparison with control cells. Collectively, the results suggest that barbatimão could exert genoprotective and antiapoptotic effects on human keratinocytes and fibroblasts.Keywords
Funding Information
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (402325/2013-3, 490760/2013-9, 311446/2012-4)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (402325/2013-3, 490760/2013-9, 311446/2012-4)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (402325/2013-3, 490760/2013-9, 311446/2012-4)
- Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul (402325/2013-3, 490760/2013-9, 311446/2012-4)
- Fundação de Amparo à Pesquisa do Estado do Amazonas (402325/2013-3, 490760/2013-9, 311446/2012-4)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (402325/2013-3, 490760/2013-9, 311446/2012-4)
This publication has 33 references indexed in Scilit:
- Methotrexate-Related Response on Human Peripheral Blood Mononuclear Cells May Be Modulated by the Ala16Val-SOD2 Gene PolymorphismPLOS ONE, 2014
- Genomodifier capacity assay: a non-cell test using dsDNA molecules to evaluate the genotoxic/genoprotective properties of chemical compoundsAnalytical Methods, 2014
- Methyl protodioscin induces G2/M cell cycle arrest and apoptosis in A549 human lung cancer cellsPharmacognosy Magazine, 2014
- Optimization of Ultrasound-assisted extraction of polyphenols, tannins and epigallocatechin gallate from barks of Stryphnodendron adstringens (Mart.) Coville bark extractsPharmacognosy Magazine, 2014
- Stryphnodendron adstringens extract associated with the hooves trimming surgical procedure for the treatment of bovine digital dermatitisTropical Animal Health and Production, 2013
- Acute and Chronic Toxicity of an Aqueous Fraction of the Stem Bark ofStryphnodendron adstringens(Barbatimão) in RodentsEvidence-Based Complementary and Alternative Medicine, 2013
- Safety evaluation of proanthocyanidin polymer-rich fraction obtained from stem bark of Stryphnodendron adstringens (BARBATIMÃO) for use as a pharmacological agentRegulatory Toxicology and Pharmacology, 2010
- Wound-healing evaluation of ointment from Stryphnodendron adstringens (barbatimão) in rat skinBrazilian Journal of Pharmaceutical Sciences, 2010
- Development and validation of a LC-method for the determination of phenols in a pharmaceutical formulation containing extracts from Stryphnodendron adstringensQuímica Nova, 2010
- Tannin composition of barbatimão speciesFitoterapia, 2002